<DOC>
	<DOCNO>NCT00978796</DOCNO>
	<brief_summary>The purpose study determine effect sitagliptin glucose variability meal overnight adult patient type 1 diabetes .</brief_summary>
	<brief_title>Assessing Glucose Effects Sitagliptin ( Januvia ) Adult Patients With Type 1 Diabetes</brief_title>
	<detailed_description>Improved post prandial glucose control multiple daily injection insulin DCCT study demonstrate significant reduction microvascular complication . Similar type 2 diabetes , patient type 1 diabetes paradoxical increase glucagon meal contribute worsen post prandial glucose control . This propose study design determine alter glucagon axis give sitagliptin improve glucose control patient type 1 diabetes .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<criteria>Male female adult , age 18 70 year Type 1 diabetes mellitus establish medical history Current treatment MDI CSII therapy least 3 month prior screen visit ; use insulin last 1 month HbA1c ≥ 8.5 % Subjects routinely practice least 24 blood glucose measurement per day BMI ≤ 35 kg/m2 Subject must able willing perform selfblood glucose monitoring accept wear continuous glucose monitor total duration study Willing complete routine medical visit every 3 month Willing complete total 7 phone visit Able speak , read , write English On oral , inhaled premixed insulin On Symlin BMI &gt; 35 kg/m2 Pregnant intend become pregnant course study Severe unexplained hypoglycemia require emergency treatment past 3 month History hemoglobinopathy Diagnosis anemia HbA1C great 12 % Postrenal transplantation , currently undergo dialysis , creatinine &gt; 1.5mg/dl calculated creatinine clearance &lt; 50 mL/min . Have extensive skin changes/diseases inhibit wear sensor normal skin Subjects medical know allergy adhesive Subjects allergy medication use Currently participation another investigational study protocol . Must complete previous study least 30 day prior enrol one Have condition , opinion Investigator , would interfere participation trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>Diabetes Mellitus</keyword>
	<keyword>Type 1 diabetes</keyword>
	<keyword>glucose variability</keyword>
</DOC>